Apogee Therapeutics
$135.07
30
-$0.01-0.01% Wednesday 20:00
+$0.04+0.03%Wednesday 23:29After hours
Statistics
Day High
135.09
Day Low
135.06
52W High
135.09
52W Low
35.39
Volume
4,970,329
Avg. Volume
2,793,147
Mkt Cap
10.22B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.22
-1.13
-1.04
-0.95
Expected EPS
-1.154749
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-255.84MNet Income
Analyst Ratings
135.52Average Price Target
The highest estimate is 140.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy 8%
Hold 92%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow APGE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Show more...
CEO
Michael Thomas Henderson
Employees
261
Country
United States
ISIN
US03770N1019
Listings
0 Comments
Share your thoughts
FAQ
What is Apogee Therapeutics stock price today?▼
The current price of APGE is $135.07 USD — it has decreased by -0.01% in the past 24 hours. Watch Apogee Therapeutics stock price performance more closely on the chart.
What is Apogee Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Apogee Therapeutics stocks are traded under the ticker APGE.
Is Apogee Therapeutics stock price growing?▼
APGE stock has risen by +0.07% compared to the previous week, the month change is a +0.63% rise, over the last year Apogee Therapeutics has showed a +256.67% increase.
What is Apogee Therapeutics market cap?▼
Today Apogee Therapeutics has the market capitalization of 10.22B
When is the next Apogee Therapeutics earnings date?▼
Apogee Therapeutics is going to release the next earnings report on November 16, 2026.
What were Apogee Therapeutics earnings last quarter?▼
APGE earnings for the last quarter are -1.14 USD per share, whereas the estimation was -1.07 USD resulting in a -6.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Apogee Therapeutics revenue for the last year?▼
Apogee Therapeutics revenue for the last year amounts to 0 USD.
What is Apogee Therapeutics net income for the last year?▼
APGE net income for the last year is -255.84M USD.
How many employees does Apogee Therapeutics have?▼
As of September 05, 2026, the company has 261 employees.
In which sector is Apogee Therapeutics located?▼
Apogee Therapeutics operates in the Health & Wellness sector.
When did Apogee Therapeutics complete a stock split?▼
The last stock split for Apogee Therapeutics was on January 08, 2008 with a ratio of 1:50.
Where is Apogee Therapeutics headquartered?▼
Apogee Therapeutics is headquartered in SAN FRANCISCO, United States.